Tuberc Respir Dis > Volume 68(4); 2010 > Article
Tuberculosis and Respiratory Diseases 2010;68(4):226-230.
DOI: https://doi.org/10.4046/trd.2010.68.4.226    Published online April 1, 2010.
Bicalutamide-induced Interstitial Lung Disease.
Yang Kyun Kim, Yee Hyung Kim, Jae Jin Lee, Cheon Woong Choi, Jee Hong Yoo, Myung Jae Park, Hong Mo Kang
1Department of Pulmonary and Critical Care Medicine, East-West Neo Medical Center, Kyung Hee University School of Medicine, Seoul, Korea. yeehyung@gmail.com
2Department of Hematology and Oncology, East-West Neo Medical Center, Kyung Hee University School of Medicine, Seoul, Korea.
3Department of Pulmonary and Critical Care Medicine, Kyung Hee University Medical Center, Kyung Hee University School of Medicine, Seoul, Korea.
Abstract
Androgen deprivation therapy, which is the standard treatment for metastatic prostate cancer, includes nonsteroidal antiandrogenic drugs, such as flutamide, nilutamide and bicalutamide. Of them, bicalutamide rarely induces interstitial pneumonia. We report a case of bicalutamide-induced interstitial pneumonia. A 68-year old male diagnosed with prostate cancer and multiple bone metastases presented with dry cough and low grade fever for 3 days. He had taken bicalutamide (50 mg/day) for 13 months. High resolution computed tomography revealed ground glass opacity in his right upper lung. The laboratory studies showed no eosinophilia in the serum and bronchoalveolar lavage fluid. Despite the use of antimicrobial agents for 2 weeks, the extent of the lung lesions increased to the left upper and right lower lung. He had no environmental exposure, collagen vascular disease and microbiological causes. Under the suspicion of bicalutamide-induced interstitial pneumonia, bicalutamide was stopped and prednisolone (1 mg/kg/day) was initiated. The symptoms and radiologic abnormalities were resolved with residual minimal fibrosis.
Key Words: Bicalutamide, Lung Diseases, Interstitial, Prostatic Neoplasms


ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2022 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next